You're reading the free version. Trader adds the live tape and alerts.
Start tracking
JAZZ Sale Disclosure
Carr Patricia · SEC Form 4 · Filed Nov 6, 2026
Sale
Calculated transaction value
$289.21K
Carr Patricia SVP, Chief Accounting Officer
JAZZ
Jazz Pharmaceuticals
JAZZ
Transaction date
Nov 4, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed 2 days later
JAZZ daily price context
Close on/before transaction
$234.66
Nov 4, 2026
First close after public filing
$243.54
Nov 9, 2026
Return after filing · so far
+1.9%
Through Nov 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 1,250 shares @ $231.37
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001784606-26-000018
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$501.95K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Jazz Pharmaceuticals Plc JAZZ Current | Sale | Nov 4, 2026 | $289.21K |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Nov 4, 2026 | $175.04K |
| Jazz Pharmaceuticals Plc JAZZ | Sale | Nov 4, 2026 | $37.7K |
| Jazz Pharmaceuticals Plc JAZZ | Exercise | Nov 4, 2026 | $0 |